Norway · Delayed Price · Currency is NOK CTI BioPharma Statistics
Total Valuation
OSL:ELIMP has a market cap or net worth of NOK 812.52 million. The enterprise value is 1.39 billion.
| Market Cap | 812.52M |
| Enterprise Value | 1.39B |
Important Dates
The next estimated earnings date is Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:ELIMP has 50.78 million shares outstanding. The number of shares has increased by 54.57% in one year.
| Current Share Class | 50.78M |
| Shares Outstanding | 50.78M |
| Shares Change (YoY) | +54.57% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.60% |
| Owned by Institutions (%) | 24.26% |
| Float | 24.93M |
Valuation Ratios
The trailing PE ratio is 16.90 and the forward PE ratio is 16.43.
| PE Ratio | 16.90 |
| Forward PE | 16.43 |
| PS Ratio | 0.49 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 5.53 |
| P/FCF Ratio | 9.02 |
| P/OCF Ratio | 7.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.08, with an EV/FCF ratio of 15.43.
| EV / Earnings | 31.15 |
| EV / Sales | 0.83 |
| EV / EBITDA | 9.08 |
| EV / EBIT | 27.77 |
| EV / FCF | 15.43 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.00.
| Current Ratio | 1.47 |
| Quick Ratio | 0.45 |
| Debt / Equity | 1.00 |
| Debt / EBITDA | 4.38 |
| Debt / FCF | 7.44 |
| Interest Coverage | 1.08 |
Financial Efficiency
Return on equity (ROE) is 7.11% and return on invested capital (ROIC) is 2.40%.
| Return on Equity (ROE) | 7.11% |
| Return on Assets (ROA) | 2.00% |
| Return on Invested Capital (ROIC) | 2.40% |
| Return on Capital Employed (ROCE) | 4.13% |
| Revenue Per Employee | 4.12M |
| Profits Per Employee | 109,855 |
| Employee Count | 412 |
| Asset Turnover | 1.07 |
| Inventory Turnover | 3.10 |
Taxes
In the past 12 months, OSL:ELIMP has paid 890,000 in taxes.
| Income Tax | 890,000 |
| Effective Tax Rate | 1.96% |
Stock Price Statistics
The stock price has increased by +63.60% in the last 52 weeks. The beta is 0.92, so OSL:ELIMP's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +63.60% |
| 50-Day Moving Average | 15.41 |
| 200-Day Moving Average | 13.08 |
| Relative Strength Index (RSI) | 52.22 |
| Average Volume (20 Days) | 21,844 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:ELIMP had revenue of NOK 1.67 billion and earned 44.60 million in profits. Earnings per share was 0.95.
| Revenue | 1.67B |
| Gross Profit | 575.43M |
| Operating Income | 50.04M |
| Pretax Income | 45.46M |
| Net Income | 44.60M |
| EBITDA | 71.62M |
| EBIT | 50.04M |
| Earnings Per Share (EPS) | 0.95 |
Balance Sheet
The company has 95.00 million in cash and 670.00 million in debt, giving a net cash position of -575.00 million or -11.32 per share.
| Cash & Cash Equivalents | 95.00M |
| Total Debt | 670.00M |
| Net Cash | -575.00M |
| Net Cash Per Share | -11.32 |
| Equity (Book Value) | 668.00M |
| Book Value Per Share | 13.11 |
| Working Capital | 178.00M |
Cash Flow
In the last 12 months, operating cash flow was 114.19 million and capital expenditures -24.16 million, giving a free cash flow of 90.03 million.
| Operating Cash Flow | 114.19M |
| Capital Expenditures | -24.16M |
| Free Cash Flow | 90.03M |
| FCF Per Share | 1.77 |
Margins
Gross margin is 34.40%, with operating and profit margins of 2.99% and 2.67%.
| Gross Margin | 34.40% |
| Operating Margin | 2.99% |
| Pretax Margin | 2.72% |
| Profit Margin | 2.67% |
| EBITDA Margin | 4.28% |
| EBIT Margin | 2.99% |
| FCF Margin | 5.38% |
Dividends & Yields
OSL:ELIMP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.57% |
| Shareholder Yield | n/a |
| Earnings Yield | 5.49% |
| FCF Yield | 11.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OSL:ELIMP has an Altman Z-Score of 1.9 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.9 |
| Piotroski F-Score | 6 |